mhurhangee/ep-ind-claims huggingface dataset:
A method of manufacturing a wear resistant surface layer comprising the steps of: • applying a dry powder layer comprising a mix of refined fibres, binder, pigments and wear resistant particles on a carrier; and • curing the mix to a pale colored wear resistant layer by applying heat and pressure on the mix. • applying a dry powder layer comprising a mix of refined fibres, binder, pigments and wear resistant particles on a carrier; and • curing the mix to a pale colored wear resistant layer by applying heat and pressure on the mix.
An electrochromic compound represented by a general formula: wherein: - Z is a pyridinediyl radical or a pyridiniumdiyl radical; - each Y is independently selected from N or ( + N-R 2)(X -) with R 2 a C 1 -C 18 alkyl; - each one of R 1 is independently selected from H, alkyl, alkoxy, alkylthio, haloalkyl, haloalkoxy, haloalkylthio, polyalkylenoxy, alkoxycarbonyl, aryl, or heteroaryl; - n is 1, 2, 3 or 4; - a is 4; - X- is a counterion; - Z is not simultaneously bound in position 4 of cycle A and in position 4 of cycle B. - Z is a pyridinediyl radical or a pyridiniumdiyl radical; - each Y is independently selected from N or ( + N-R 2)(X -) with R 2 a C 1 -C 18 alkyl; - each one of R 1 is independently selected from H, alkyl, alkoxy, alkylthio, haloalkyl, haloalkoxy, haloalkylthio, polyalkylenoxy, alkoxycarbonyl, aryl, or heteroaryl; - n is 1, 2, 3 or 4; - a is 4; - X- is a counterion; - Z is not simultaneously bound in position 4 of cycle A and in position 4 of cycle B.
A computer-implemented undo system, comprising: a change component adapted for tracking asynchronous data changes to data via a web application, wherein the asynchronous data changes are changes that require asynchronous validations or augmentations; a reverse component adapted for performing multi-level undo/redo reverse operations on the asynchronous data changes, the reverse component comprising an undo stack adapted for storing explicit changes and implicit changes, wherein an undo command removes and reverts changes from the undo stack until an explicit change is reverted; and a data grid adapted for providing a tabular representation of the data stored in the web application, comprising cells for recording the asynchronous data changes, to support editing and visualization of the asynchronous data changes, the data grid being adapted to send a notification to the web application associated with the asynchronous data changes, wherein the notification includes an order key that facilitates ordering of the changes at the grid relative to other data changes. a change component adapted for tracking asynchronous data changes to data via a web application, wherein the asynchronous data changes are changes that require asynchronous validations or augmentations; a reverse component adapted for performing multi-level undo/redo reverse operations on the asynchronous data changes, the reverse component comprising an undo stack adapted for storing explicit changes and implicit changes, wherein an undo command removes and reverts changes from the undo stack until an explicit change is reverted; and a data grid adapted for providing a tabular representation of the data stored in the web application, comprising cells for recording the asynchronous data changes, to support editing and visualization of the asynchronous data changes, the data grid being adapted to send a notification to the web application associated with the asynchronous data changes, wherein the notification includes an order key that facilitates ordering of the changes at the grid relative to other data changes.
Method for joining a first blank and a second blank wherein the first blank and the second blank comprises a steel substrate with a coating comprising a layer of aluminum or an aluminum alloy, the method comprising - selecting a first portion of the first blank to be joined to the second blank, and selecting a second portion of the second blank to be joined to the first portion, - welding the first portion to the second portion, wherein - welding comprises using a laser beam and an arc welding torch, wherein - the arc welding torch comprises a filler wire electrode, wherein - the filler wire electrode is made of a steel alloy comprising gammagenic elements, optionally a stainless steel alloy comprising gammagenic elements and, - displacing both the laser beam and the arc welding torch in a welding direction, the first portion and the second portion of the blanks in the weld zone being melted during welding, characterised in that, in the welding direction, the arc welding torch is positioned in front of the laser beam. - selecting a first portion of the first blank to be joined to the second blank, and selecting a second portion of the second blank to be joined to the first portion, - welding the first portion to the second portion, wherein - welding comprises using a laser beam and an arc welding torch, wherein - the arc welding torch comprises a filler wire electrode, wherein - the filler wire electrode is made of a steel alloy comprising gammagenic elements, optionally a stainless steel alloy comprising gammagenic elements and, - displacing both the laser beam and the arc welding torch in a welding direction, the first portion and the second portion of the blanks in the weld zone being melted during welding, characterised in that, in the welding direction, the arc welding torch is positioned in front of the laser beam.
An implant fixture comprising an elongated body extending along a longitudinal axis, wherein the elongated body has a first end and a second end and includes: a base portion having a non-circular cross section and a receiver adapted to receive a prosthetic; a root portion extending from the base portion away from the receiver; and an extension portion extending from the root portion away from the base portion, the extension portion extending primarily along a first side of the longitudinal axis, wherein an interface between the root portion and the extension portion comprises a generally convex face, wherein said elongated body includes a collar that extends approximately 0.5 mm from said first end toward said second end 520 and a rougher surface that extends below said collar toward said second end.
A battery device, comprising a box frame, and battery groups and first beams located in the box frame, wherein an adhesive layer is provided between each of the first beams and a first side surface of an adjacent one of the battery groups, the adhesive layer is formed as each of the first beams and the first side surface of the adjacent one of the battery groups are mutually pressed in a first direction (x characterized in that, a side of one of the first beams located at an end portion facing away from the battery groups is adjacent to the box frame and is separated from the box frame by a first set interval (s), and the first set interval (s) is configured to allow the first beam at the end portion to move towards the first side surface of the battery group for adhering.
An electrochromic, EC, system, comprising: an EC device comprising: a working electrode; a counter electrode; a solid state electrolyte layer disposed between the counter and working electrodes; and a control unit configured to selectively apply a sweep voltage between the working and counter electrodes, such that the sweep voltage is applied when an open circuit voltage between the working and counter electrodes is less than a threshold voltage, further comprising a voltage detector configured to detect the open circuit voltage, wherein: the control unit is configured to apply the sweep voltage when the voltage detector detects that the open circuit voltage is below the threshold voltage; the threshold voltage is between 0V and -2V; the sweep voltage is a positive voltage and results in an increase in the transparency of the electrochromic device, and the magnitude of the sweep voltage is greater than or equal to the magnitude of the open circuit voltage. an EC device comprising: a working electrode; a counter electrode; a solid state electrolyte layer disposed between the counter and working electrodes; and a working electrode; a counter electrode; a solid state electrolyte layer disposed between the counter and working electrodes; and a control unit configured to selectively apply a sweep voltage between the working and counter electrodes, such that the sweep voltage is applied when an open circuit voltage between the working and counter electrodes is less than a threshold voltage, further comprising a voltage detector configured to detect the open circuit voltage, wherein: the control unit is configured to apply the sweep voltage when the voltage detector detects that the open circuit voltage is below the threshold voltage; the threshold voltage is between 0V and -2V; the sweep voltage is a positive voltage and results in an increase in the transparency of the electrochromic device, and the magnitude of the sweep voltage is greater than or equal to the magnitude of the open circuit voltage. the control unit is configured to apply the sweep voltage when the voltage detector detects that the open circuit voltage is below the threshold voltage; the threshold voltage is between 0V and -2V; the sweep voltage is a positive voltage and results in an increase in the transparency of the electrochromic device, and the magnitude of the sweep voltage is greater than or equal to the magnitude of the open circuit voltage.
[Glu 22,25, Leu 23,28,31, Aib 29, Lys 26,30] hPTHrP NH 2 for use in treating osteoporosis, wherein the use comprises once per day administration of from about 75 μg to about 80 μg of [Glu 22,25, Leu 23,28,31, Aib 29, Lys 26,30] hPTHrP NH 2 to a human in need thereof.
A color target, the color target comprising: a substrate having a target surface; a sample window formed in the substrate and defining a perimeter within which a sample surface is disposed; and one or more filters (332, 334, 336) disposed over the sample surface, wherein the one or more filters (332, 334, 336) is configured to cover a first portion of the sample surface, while leaving a second portion of the sample surface uncovered, characterized by a dark patch (316, 318) disposed on the target surface for facilitating estimation of a spectral reflectance associated with the target surface and/or the sample surface; wherein at least one of the one or more filters (332, 334, 336) extends beyond the perimeter of the sample window to cover at least a portion of the dark patch and/or wherein the color target comprises a further filter disposed over at least a portion of the dark patch, the further filter having a transmittance spectrum that is substantially identical to that of at least one of the one or more filters (332, 334, 336) disposed over the sample surface. a substrate having a target surface; a sample window formed in the substrate and defining a perimeter within which a sample surface is disposed; and one or more filters (332, 334, 336) disposed over the sample surface, wherein the one or more filters (332, 334, 336) is configured to cover a first portion of the sample surface, while leaving a second portion of the sample surface uncovered, characterized by a dark patch (316, 318) disposed on the target surface for facilitating estimation of a spectral reflectance associated with the target surface and/or the sample surface; wherein at least one of the one or more filters (332, 334, 336) extends beyond the perimeter of the sample window to cover at least a portion of the dark patch and/or wherein the color target comprises a further filter disposed over at least a portion of the dark patch, the further filter having a transmittance spectrum that is substantially identical to that of at least one of the one or more filters (332, 334, 336) disposed over the sample surface.
A nucleic acid comprising miR27b or a nucleotide having the nucleotide sequence shown by SEQ ID NO: 1, for use in the treatment of a tumor, wherein the tumor is drug-resistant breast cancer or drug-resistant lung cancer, and wherein the drug-resistant breast cancer is adriamycin-resistant breast cancer and the drug-resistant lung cancer is cisplatin-resistant lung cancer.
A lid for a container holding a flowable substance, which comprises a top wall, a side wall and a mounting portion to be attached to the container and an opening to remove the flowable substance from the container, whereas the opening is opened and closed by means of a slider, which rotates around a vertical axis and which is connected to the lid by a convexity in the lid and an opening in the slider, wherein the connection is a form-fit and/or force-fit-connection and wherein the slider has a first end (10.1) and a second end (10.2), wherein the slider is connected to the lid at the second end (10.2), wherein, the top wall comprises an annular ring, in which the opening is provided and wherein the slider is U-shaped at its first end (10.1) and sealing means is arranged at the base of the U, which seals the opening in the lid and wherein the U at least partially encompasses the annular ring, characterized in that the convexity is a truncated cone whose diameter increases with its height and in that the opening in the slider is a circle with a smaller diameter than the largest outer diameter of the cross section of the truncated cone.
A method for transmitting Uplink Control Information, UCI, in a wireless communication device, in a situation in which a plurality of cells is configured in a wireless communication system, the method comprising: generating UCI; and determining a Physical Uplink Control Channel, PUCCH, resource for transmitting the UCI, wherein, if reception response information and channel state information are triggered in the same subframe, only first UCI generated from the reception response information is transmitted through a first PUCCH, if the reception response information and scheduling request information are triggered in the same subframe, second UCI generated by joint coding the reception response information and the scheduling request information is transmitted through a second PUCCH, characterized in that a UCI data part for the first PUCCH and a UCI data part for the second PUCCH have same Physical Resource Block, PRB, and Orthogonal Cover Code, OCC, and in that at least one of a Cyclic Shift, CS, an OCC and a combination of CS and OCC of a reference signal for the first PUCCH is different from that of a reference signal for the second PUCCH. generating UCI; and determining a Physical Uplink Control Channel, PUCCH, resource for transmitting the UCI, wherein, if reception response information and channel state information are triggered in the same subframe, only first UCI generated from the reception response information is transmitted through a first PUCCH, if the reception response information and scheduling request information are triggered in the same subframe, second UCI generated by joint coding the reception response information and the scheduling request information is transmitted through a second PUCCH, characterized in that a UCI data part for the first PUCCH and a UCI data part for the second PUCCH have same Physical Resource Block, PRB, and Orthogonal Cover Code, OCC,
Process for producing an electrical contact between an aluminium component part and a piezoceramic component, in which the earth contact of the piezoceramic component makes electrical contact with the surface of the aluminium component part, an oxide layer on the aluminium surface being removed in a first step, characterized in that, in a second step, before an oxide layer is re-formed, the surface is sealed with a conversion layer having incorporated metal ions.
A method of identifying a mammalian cell that produces a heterodimeric molecule of interest, the method comprising: (a) transfecting a mammalian cell that expresses a first polypeptide with a polynucleotide that encodes at least one second polypeptide, wherein the first polypeptide comprises (i) an extracellular portion that comprises an immunoglobulin heavy chain constant region comprising CH2 and CH3 domains; and (ii) a non-immunoglobulin transmembrane portion; and does not comprise an immunoglobulin heavy chain variable region; wherein the second polypeptide comprises an immunoglobulin heavy chain and an immunoglobulin light chain which form a single antigen-binding site; and, wherein the first polypeptide forms at least one disulfide bond with the second polypeptide to form a heterodimeric molecule that is expressed on the surface of the cell; said heterodimeric molecule comprising the antigen-binding site; (b) contacting the mammalian cell with a detection molecule, wherein the detection molecule binds the antigen-binding site of the heterodimeric molecule; and (c) identifying the mammalian cell bound by the detection molecule. (a) transfecting a mammalian cell that expresses a first polypeptide with a polynucleotide that encodes at least one second polypeptide, wherein the first polypeptide comprises (i) an extracellular portion that comprises an immunoglobulin heavy chain constant region comprising CH2 and CH3 domains; and (ii) a non-immunoglobulin transmembrane portion; and does not comprise an immunoglobulin heavy chain variable region; wherein the second polypeptide comprises an immunoglobulin heavy chain and an immunoglobulin light chain which form a single antigen-binding site; and, wherein the first polypeptide forms at least one disulfide bond with the second polypeptide to form a heterodimeric molecule that is expressed on the surface of the cell; said heterodimeric molecule comprising the antigen-binding site; (b) contacting the mammalian cell with a detection molecule, wherein the detection molecule binds the antigen-binding site of the heterodimeric molecule; and (c) identifying the mammalian cell bound by the detection molecule.
A cleavable substrate of Trichomonas vaginalis purine nucleoside phosphorylase enzyme for use in the inhibition of a mammalian cancerous cell or a virally infected cell wherein said cleavable substrate is converted into cytotoxic purine analog by providing a Trichomonas vaginalis purine nucleoside phosphorylase enzyme in proximity to the cancerous mammalian cell or the virally infected cell wherein the cleavable substrate is 9-(β-D-arabinofuranosyl)-2-fluoroadenine (fludarabine) and wherein the Trichomonas vaginalis purine nucleoside phosphorylase enzyme has the sequence of SEQ ID NO:5 or wherein the cleavable substrate is selected from the group consisting of 9-(β-D-arabinofuranosyl)-2-fluoroadenine (fludarabine), cladribine, 5'-methyl(talo)-6-methyl-purine-riboside, 5'-methyl(talo)-2'-deoxy-6-methylpurine-riboside, 5'-methyl(allo)-6-methylpurine-riboside, 2-F-5'-deoxyadenosine and 2-F-α-L-lyxo-adenine and wherein a tail mutant of Trichomonas vaginalis purine nucleoside phosphorylase enzyme has a sequence selected from the group consisting of SEQ ID NO:8, SEQ ID NO:10 or SEQ ID NO:12
A device for attaching a balancing weight to a mounting surface on an inner side of a rim dish of a wheel rim, comprising a mounting head which is dimensioned in such a way that it fits into the rim dish and which includes a support element, which is radially displaceable relative to the wheel rim and on which a feeler element is axially movably arranged, wherein the feeler element has at its free end a feeler head, which is configured such that it is movable into a cavity of the wheel rim and the feeler head comprises a receptacle for at least one balancing weight, that is aligned towards the rim inner side and has a convex curved surface, and the side of the feeler head facing the rim inner side is bent radially according to the curvature of the rim inner side, wherein adjacent to the receptacle a convex contact surface with a circularly curved edge region is arranged, and wherein the mounting head being configured in such a way that the contact surface can be brought into contact with a boundary surface of the inner side, and may be displaced along said boundary surface until the balancing weight comes radially into contact with the mounting surface.
Method for actuating the cruise control function in a vehicle equipped with hybrid driving, especially an industrial or commercial vehicle, said hybrid driving comprising at least a primary driving and an electric driving, the method comprising, when said cruise control function is required, the steps of: - cyclic check of the possibility of activation of said cruise control function; if positive - activation of said electric driving of the type "electric cruise-control" (ElCC), and deactivation of said primary driving, if a cyclic check of the conditions of activation of the electric driving is positive; otherwise - activation of said primary driving of the type "engine cruise-cruise control" (EnCC), and deactivation of said electric driving, wherein said cyclic check of the possibility of activation of the cruise control function comprises: - check if the vehicle's speed exceeds a speed threshold value; - check if the vehicle is moving forward, and, wherein - if a road slope is lower than a slope threshold value (Pmax); - if a target speed (Vset) set for the activation of the cruise control function is lower than a speed threshold value (Vmax); - if the state of charge of the driving battery of said electric driving is higher than a state of charge threshold value (SOCs); - if an instant power required to said electric driving is lower than a power limit value (PLIMIT-Mot) deliverable by said electric driving, the method being characterized in that one or more values of said slope threshold values (Pmax), speed threshold value (Vmax), state of charge threshold value (SOCs), deliverable power limit value (PLIMIT-Mot), are variable within respective tolerated percentage variations around the respective values,, wherein the tolerated percentage variation (SOC_Hyst) of battery state of charge (SOCs), is variable as a function of indications and data deriving from a vehicular navigation system of the three-dimensional type, comprising both an instant and a predictive road slope indication, and an indication of the weight of the vehicle. - cyclic check of the possibility of activation of said cruise control function; if positive - activation of said electric driving of the type "electric cruise-control" (ElCC), and deactivation of said primary driving, if a cyclic check of the conditions of activation of the electric driving is positive; otherwise - activation of said primary driving of the type "engine cruise-cruise control" (EnCC), and deactivation of said electric driving, - check if the vehicle's speed exceeds a speed threshold value; - check if the vehicle is moving forward, and, wherein - if a road slope is lower than a slope threshold value (Pmax); - if a target speed (Vset) set for the activation of the cruise control function is lower than a speed threshold value (Vmax); - if the state of charge of the driving battery of said electric driving is higher than a state of charge threshold value (SOCs); - if an instant power required to said electric driving is lower than a power limit value (PLIMIT-Mot) deliverable by said electric driving,